Research Article
BibTex RIS Cite

Paroksismal atriyal fibrilasyonu olan hastalarda paroksismal atriyal fibrilasyonun öngörülmesinde doku Doppler görüntüleme ve zirve hızlanma süresi

Year 2020, 2020 Özel Sayı, 61 - 67, 26.02.2020
https://doi.org/10.18663/tjcl.615645

Abstract

Amaç: Atriyal fibrilasyon, popülasyonda
en sık görülen aritmidir ve prevalansı yaşla artar  ayrıca en sık
rastlanılan morbidite ve mortalite oluşturan aritmidir. Genellikle persistan
atriyal fibrilasyonun başlangıcı paroksismal atriyal fibrilasyonun (PAF)
tekrarlayan bölümleridir. Paroksismal atriyal fibrilasyonun öngörülmesi, bu
aritminin önlenmesine ve dolayısıyla olumsuz sonuçların önlenmesine neden
olabilir. Bu çalışmada paroksismal atriyal fibrilasyonu öngörebilecek doku
Doppler görüntüleme (TDI) ve pik hızlanma süresi (pkAcc) parametrelerini
araştırmayı amaçladık.



Gereç ve Yönetemler: 20-73 yaşları arasında (ortalama
47,5) PAF tanısı almış 50 kişi ile hasta grubu oluşturuldu.. Hasta grubu ile
benzer temel demografik özelliklere sahip olan ve persistan veya PAF bulunmayan
50 kişi ile kontrol grubu oluşturuldu.Tüm kontrol ve çalışma gruplarına
transtorasik ekokardiyografik (TTE) değerlendirme yapıldı. Doku Doppler
parametreleri ve pkAcc TTE'de ölçüldü ve istatistiksel analizler yapıldı.



Bulgular: TTE değerlendirmesinde, hasta
grubunda sol atriyum ejeksiyon fraksiyonu çalışma grubundan daha düşüktü (%
50,6 vs.% 59,2, p <0,001). TDI değerlendirmesinde, sol ventrikülün
anterior, inferior, lateral ve septal duvarlarından ölçülen E / E 'nin
ortalaması; Hasta grubunda kontrol grubuna göre daha yüksek bulundu (8,17 ve
7,04; p = 0,004). İki grup pkAcc açısından karşılaştırıldığında, hasta grubunun
daha yüksek olduğu bulundu ancak bu fark istatistiksel olarak anlamlı bulunmadı
(1063'e karşı 994, p = 0,14). 



Sonuç: TDI değerlendirmesi paroksismal
atriyal fibrilasyonun öngörülmesinde önemli bir rol oynayabilir.

References

  • 1. Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation: Analysis of Pooled Data From Five Randomized Controlled Trials. Arch Intern Med 1994; 154: 1449–57.
  • 2. Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke 1988; 19: 937.
  • 3. Craig T. January, L. Samuel W et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, JACC VOL 2014: 64: 2246 – 80
  • 4. European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Scoiety (ECAS), American College of Cardiology (ACC), et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4:816.
  • 5. Miyatake K, Yamagishi M, Tanaka N, et al. New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging: in vitro and in vivo studies. J Am Coll Cardiol 1995; 25: 717–24.
  • 6. Madler CF, Payne N, Wilkenshoff U et al. Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: Optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J 2003; 24: 1584–94.
  • 7. Ommen SR, Nishimura RA, Appleton CP et al . Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000; 102: 1788–94.
  • 8. Modesto KM, Dispenzieri A, Cauduro SA et al. Left atriyal myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J 2005; 26: 173–79.
  • 9. A. V. Mattioli, D Vivoli and E Bastia. Doppler echocardiographic parameters predictive of recurrence of atriyal fibrillation of different etiologic origins. JUM 1997; 16: 695-98
  • 10. Apurva O. Badheka, Ankit Rathod, Mohammad A. Kizilbash et al. comparison of mortality and morbidity in patients with atrialfibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Am J Cardiol 2011;108: 1283–88
  • 11. Olsson G. L, Swedberg K, Ducharme A et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction. J Am Coll Cardiol 2006; 47: 1997–2004
  • 12. Jeffrey W.H. Fung, John e. Sanderson, Gabrıel W.K. Yıp, Qıng Zhang , Cheuk M. YU . ımpact of atrial fibrillation in heart failure with normalejection fraction: a clinical and echocardiographic study. J Cardiac Fail 2007; 13: 649-55
  • 13. Ahmed Salah, Hui Yang, Liang Tang, Xuping Li, Qiming Liu, Shenghua Zhou. Left atrial dyssynchrony time measured by tissue Doppler imaging to predict atrial fibrillation recurrences after pulmonary vein isolation. Anatolian J Cardiol 2015; 15: 115-22
  • 14. Teresa S. M. Tsang, Bernard J. Gersh, Christopher P. Appleton et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636–44)
  • 15. Malik A. Al-Omari, Joshua Finstuen, Christopher P et al. echocardiographic assessment of left ventricular diastolic function and filling pressure in atrial fibrillation. Am J Cardiol 2008; 101: 1759 –65
  • 16. Sherif F. Nagueh, Christopher P. Appleton et al. recommendations for the evaluation of left ventriculardiastolic function by echocardiography. Journal of the American Society of Echocardiography 2009; 22: 107–33
  • 17. Walter P. Abhayaratna, Kaniz Fatema, Marion E. Barnes et al. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons >65 years of age. Am J Cardiol 2008; 101:1626 –29)
  • 18. Stahrenberg R, Edelmann F, Haase B et al. transthoracic echocardiography to rule out paroxysmalatrial fibrillation as a cause of stroke or transient ischemic attack. Stroke. 2011; 42: 3643-45
  • 19. Sherif F. Nagueh, Helen A. Kopelen, Miguel A. Quin˜ones. Assessment of left ventricular filling pressures by doppler in the presence of atrial fibrillation. Circulation 1996; 94: 2138-45
  • 20. H Okura, Y Takada, T Kubo et al. Tissue Doppler-derived index of left ventricular fillingpressure, E/E’, predicts survival of patients with nonvalvular atrial fibrillation. Heart 2006; 92: 1248–52.

Value of tissue Doppler imaging and peak acceleration time in prediction of paroxysmal atrial fibrillation in patients with paroxysmal atrial fibrillation

Year 2020, 2020 Özel Sayı, 61 - 67, 26.02.2020
https://doi.org/10.18663/tjcl.615645

Abstract

Aim: Atrial
fibrillation is the most common arrhythmia in the population and its prevalance
increases with age; and also is the most morbid and mortal arrhythmia. Usually
the beginning of the persistant atrial fibrillation is recurrent episodes of
the paroxysmal atrial fibrillation (PAF). Prediction of the paroxysmal atrial
fibrillation can cause prevention of this arrhythmia and thus prevention of the
adverse outcomes. We aimed to investigate tissue Doppler imaging (TDI) and peak
acceleration time (pkAcc) parameters that can predict the paroxysmal atrial
fibrillation in this study.



Material and Methods: 20-73
years old (mean 47,5) 50 individuals that are diagnosed with PAF included the
patient group. 50 individuals who have the similar baseline demographic
charasteristics with patient group and who have no persistant or PAF included
the control group. Transthoracic echocardiogaphic (TTE) evaluation is applied
all of the control and study groups. Tissue Doppler parameters and pkAcc is
measured in TTE and statistical analyses is performed.



Results: In
TTE evaluation, left atrium ejection fraction is lower in the patient group
than the study group (%50,6 vs. %59,2, p<0,001). In TDI evaluation, the
average of E/E’ which was measured from the anterior, inferior, lateral and
septal walls of the left ventricle; is found higher in the patient group
compared to the control group (8,17 vs. 7,04; p=0,004).  When two groups are compared in terms of
pkAcc, it was found that patient group is higher, but this difference did not
reach the statistical significance (1063 vs. 994, p=0,14).         



Conclusions: TDI
evaluation can play an important role in prediction of paroxysmal atrial
fibrillation. 

References

  • 1. Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation: Analysis of Pooled Data From Five Randomized Controlled Trials. Arch Intern Med 1994; 154: 1449–57.
  • 2. Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke 1988; 19: 937.
  • 3. Craig T. January, L. Samuel W et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, JACC VOL 2014: 64: 2246 – 80
  • 4. European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Scoiety (ECAS), American College of Cardiology (ACC), et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4:816.
  • 5. Miyatake K, Yamagishi M, Tanaka N, et al. New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging: in vitro and in vivo studies. J Am Coll Cardiol 1995; 25: 717–24.
  • 6. Madler CF, Payne N, Wilkenshoff U et al. Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: Optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J 2003; 24: 1584–94.
  • 7. Ommen SR, Nishimura RA, Appleton CP et al . Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000; 102: 1788–94.
  • 8. Modesto KM, Dispenzieri A, Cauduro SA et al. Left atriyal myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J 2005; 26: 173–79.
  • 9. A. V. Mattioli, D Vivoli and E Bastia. Doppler echocardiographic parameters predictive of recurrence of atriyal fibrillation of different etiologic origins. JUM 1997; 16: 695-98
  • 10. Apurva O. Badheka, Ankit Rathod, Mohammad A. Kizilbash et al. comparison of mortality and morbidity in patients with atrialfibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Am J Cardiol 2011;108: 1283–88
  • 11. Olsson G. L, Swedberg K, Ducharme A et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction. J Am Coll Cardiol 2006; 47: 1997–2004
  • 12. Jeffrey W.H. Fung, John e. Sanderson, Gabrıel W.K. Yıp, Qıng Zhang , Cheuk M. YU . ımpact of atrial fibrillation in heart failure with normalejection fraction: a clinical and echocardiographic study. J Cardiac Fail 2007; 13: 649-55
  • 13. Ahmed Salah, Hui Yang, Liang Tang, Xuping Li, Qiming Liu, Shenghua Zhou. Left atrial dyssynchrony time measured by tissue Doppler imaging to predict atrial fibrillation recurrences after pulmonary vein isolation. Anatolian J Cardiol 2015; 15: 115-22
  • 14. Teresa S. M. Tsang, Bernard J. Gersh, Christopher P. Appleton et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636–44)
  • 15. Malik A. Al-Omari, Joshua Finstuen, Christopher P et al. echocardiographic assessment of left ventricular diastolic function and filling pressure in atrial fibrillation. Am J Cardiol 2008; 101: 1759 –65
  • 16. Sherif F. Nagueh, Christopher P. Appleton et al. recommendations for the evaluation of left ventriculardiastolic function by echocardiography. Journal of the American Society of Echocardiography 2009; 22: 107–33
  • 17. Walter P. Abhayaratna, Kaniz Fatema, Marion E. Barnes et al. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons >65 years of age. Am J Cardiol 2008; 101:1626 –29)
  • 18. Stahrenberg R, Edelmann F, Haase B et al. transthoracic echocardiography to rule out paroxysmalatrial fibrillation as a cause of stroke or transient ischemic attack. Stroke. 2011; 42: 3643-45
  • 19. Sherif F. Nagueh, Helen A. Kopelen, Miguel A. Quin˜ones. Assessment of left ventricular filling pressures by doppler in the presence of atrial fibrillation. Circulation 1996; 94: 2138-45
  • 20. H Okura, Y Takada, T Kubo et al. Tissue Doppler-derived index of left ventricular fillingpressure, E/E’, predicts survival of patients with nonvalvular atrial fibrillation. Heart 2006; 92: 1248–52.
There are 20 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Orıgınal Artıcle
Authors

Fikret Keleş This is me 0000-0003-1012-3875

Mustafa Çelik 0000-0003-4102-1564

Recep Karatas This is me 0000-0002-3364-7586

Ahmet Erseçgin This is me 0000-0002-1687-9481

Ahmet Yilmaz 0000-0002-2753-1528

Nazif Aygul 0000-0002-0424-231X

Ahmet Avcı This is me

Publication Date February 26, 2020
Published in Issue Year 2020 2020 Özel Sayı

Cite

APA Keleş, F., Çelik, M., Karatas, R., Erseçgin, A., et al. (2020). Value of tissue Doppler imaging and peak acceleration time in prediction of paroxysmal atrial fibrillation in patients with paroxysmal atrial fibrillation. Turkish Journal of Clinics and Laboratory, 11(1), 61-67. https://doi.org/10.18663/tjcl.615645
AMA Keleş F, Çelik M, Karatas R, Erseçgin A, Yilmaz A, Aygul N, Avcı A. Value of tissue Doppler imaging and peak acceleration time in prediction of paroxysmal atrial fibrillation in patients with paroxysmal atrial fibrillation. TJCL. February 2020;11(1):61-67. doi:10.18663/tjcl.615645
Chicago Keleş, Fikret, Mustafa Çelik, Recep Karatas, Ahmet Erseçgin, Ahmet Yilmaz, Nazif Aygul, and Ahmet Avcı. “Value of Tissue Doppler Imaging and Peak Acceleration Time in Prediction of Paroxysmal Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation”. Turkish Journal of Clinics and Laboratory 11, no. 1 (February 2020): 61-67. https://doi.org/10.18663/tjcl.615645.
EndNote Keleş F, Çelik M, Karatas R, Erseçgin A, Yilmaz A, Aygul N, Avcı A (February 1, 2020) Value of tissue Doppler imaging and peak acceleration time in prediction of paroxysmal atrial fibrillation in patients with paroxysmal atrial fibrillation. Turkish Journal of Clinics and Laboratory 11 1 61–67.
IEEE F. Keleş, M. Çelik, R. Karatas, A. Erseçgin, A. Yilmaz, N. Aygul, and A. Avcı, “Value of tissue Doppler imaging and peak acceleration time in prediction of paroxysmal atrial fibrillation in patients with paroxysmal atrial fibrillation”, TJCL, vol. 11, no. 1, pp. 61–67, 2020, doi: 10.18663/tjcl.615645.
ISNAD Keleş, Fikret et al. “Value of Tissue Doppler Imaging and Peak Acceleration Time in Prediction of Paroxysmal Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation”. Turkish Journal of Clinics and Laboratory 11/1 (February 2020), 61-67. https://doi.org/10.18663/tjcl.615645.
JAMA Keleş F, Çelik M, Karatas R, Erseçgin A, Yilmaz A, Aygul N, Avcı A. Value of tissue Doppler imaging and peak acceleration time in prediction of paroxysmal atrial fibrillation in patients with paroxysmal atrial fibrillation. TJCL. 2020;11:61–67.
MLA Keleş, Fikret et al. “Value of Tissue Doppler Imaging and Peak Acceleration Time in Prediction of Paroxysmal Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation”. Turkish Journal of Clinics and Laboratory, vol. 11, no. 1, 2020, pp. 61-67, doi:10.18663/tjcl.615645.
Vancouver Keleş F, Çelik M, Karatas R, Erseçgin A, Yilmaz A, Aygul N, Avcı A. Value of tissue Doppler imaging and peak acceleration time in prediction of paroxysmal atrial fibrillation in patients with paroxysmal atrial fibrillation. TJCL. 2020;11(1):61-7.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.